Clinical Trial: Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Opioid Use Disorder
Study Type: INTERVENTIONAL
Official Title: A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of SUBLOCADE at Alternative Injection Locations in Adults
Brief Summary:
Extended-release buprenorphine (SUBLOCADE®) injection is currently approved for subcutaneous administration in 4 different quadrants of the abdomen for treatment of opioid use disorder (OUD).Injection locations are rotated to minimize irritation.Having 1 or more alternate injection sites is desirable for patients who may be taking SUBLOCADE for extended durations, based upon clinical response.The primary objective of this study is to assess the relative bioavailability of extended-release buprenorphine when…
Read more